Trial intelligence / Profile preview

Phenylephrine Administration Regimens for Cesarean Delivery

NCT00996190Phase 4Completed

Sponsor
Mount Sinai Hospital
Start
Nov 2009
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of phenylephrine in hypotension (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: The maximum decrease in cardiac output in the pre-delivery period at 30 minutes. Started Nov 2009; status: completed.

02

Drugs

phenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT00996190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00996190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call